ArticleESMO gastrointestinal oncology2026
Outcomes and management of primary tumors in metastatic MSI/dMMR colorectal cancer patients treated with immune checkpoint inhibitors: a cohort study.
L Mas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.